Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 10,444
Change Today +210.00 / 2.05%
Volume 443.2K
MDC On Other Exchanges
As of 7:58 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

mediclinic international ltd (MDC) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/23/15 - $13,459
52 Week Low
07/1/14 - $8,070
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

mediclinic international ltd (MDC) Related Businessweek News

No Related Businessweek News Found

mediclinic international ltd (MDC) Details

Mediclinic International Limited, together with its subsidiaries, operates private hospitals in South Africa, Namibia, Switzerland, and the United Arab Emirates. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 49 private hospitals in South Africa and 3 in Namibia with 7,885 beds; 16 private hospitals with 1,655 beds, and 3 clinics in Switzerland; and 2 hospitals and 10 clinics with 382 beds in the United Arab Emirates. The company was formerly known as Medi-Clinic Corporation Limited and changed its name to Mediclinic International Limited in September 2011. Mediclinic International Limited was founded in 1983 and is headquartered in Stellenbosch, South Africa.

27,352 Employees
Last Reported Date: 06/24/15
Founded in 1983

mediclinic international ltd (MDC) Top Compensated Officers

Chief Executive Officer, Executive Director, ...
Total Annual Compensation: R9.3M
Chief Financial Officer, Executive Director a...
Total Annual Compensation: R7.2M
Executive Director and Chief Executive Office...
Total Annual Compensation: R11.2M
Chief Executive Officer of Mediclinic Middle ...
Total Annual Compensation: R7.4M
Executive Director and Chief Executive Office...
Total Annual Compensation: R5.8M
Compensation as of Fiscal Year 2015.

mediclinic international ltd (MDC) Key Developments

Mediclinic International Limited, Remgro Limited, Spire Healthcare Group Plc - M&A Call

Mediclinic International Limited, Remgro Limited, Spire Healthcare Group Plc - M&A Call

Mediclinic International Limited Declares Dividend, Payable on June 22, 2015

Mediclinic International Limited announced that the directors have declared a final gross cash dividend in respect of the year under review of 75.5 cents (2014: 68.0 cents) (64.1750 cents (2014: 57.8000 cents) net of dividend withholding tax) per ordinary share. The dividend declared increased by 11% compared to the comparative period. Together with the interim dividend declared during November 2014, the total gross dividend relating to the year under review increased by 11% to 106.5 cents (2014: 96.0 cents). The dividend is payable on June 22, 2015, record date is June 19, 2015.

Mediclinic International Limited Reports Audited Consolidated Earnings Results for the Full Year Ended March 31, 2015

Mediclinic International Limited reported audited consolidated earnings results for the full year ended March 31, 2015. For the year, the company reported revenues were ZAR 35,238 million against ZAR 30,495 million a year ago. Operating profit was ZAR 5,723 million against ZAR 5,505 million a year ago. Profit before tax was ZAR 4,741 million against ZAR 4,362 million a year ago. Profit attributable to equity holders of the company was ZAR 4,297 million or 500.0 cents diluted per share against ZAR 3,385 million or 408.0 cents diluted per share a year ago. Headline earnings was ZAR 4,081 million or 474.9 cents diluted per share against ZAR 3,355 million or 404.4 cents diluted per share a year ago. Cash flow from operating activities was ZAR 6,008 million against ZAR 4,615 million a year ago. Investment to expand operations was ZAR 2,214 million against ZAR 1,679 million a year ago. Group normalised revenue increased by 16% for the period under review. Normalised operating profit before interest, tax, depreciation and amortisation (normalised EBITDA) was 11% higher at ZAR 7,179 million against ZAR 6,467 million and basic normalised headline earnings per share was 9% higher at 408.2 cents against 375.8 cents in 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDC:SJ 10,444.00 +210.00

MDC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDC.
View Industry Companies

Industry Analysis


Industry Average

Valuation MDC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICLINIC INTERNATIONAL LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at